Targeted News Service

Precision Medicine Breakthrough: Mavacamten Markedly Reduces Heart Obstruction in Teens with Hypertrophic Cardiomyopathy
March 29, 2026

PHILADELPHIA, Pennsylvania, March 29 [Category: BizHospital] -- Children's Hospital of Philadelphia issued the following news release:

* * *

Precision Medicine Breakthrough: Mavacamten Markedly Reduces Heart Obstruction in Teens with Hypertrophic Cardiomyopathy

*

Researchers at Children's Hospital of Philadelphia (CHOP) reported today that adolescents with hypertrophic cardiomyopathy (HCM) who took mavacamten experienced reduced obstr . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products

Existing Customer Login

Targeted News Service Document Request Form